Brett Marshall

This dynamic two-part session blends the energy of a live panel with the depth of small-group collaboration. The session opens with a high-impact panel discussion featuring cross-industry experts sharing insights, strategies, and perspectives on today's most pressing pharma supply chain challenges. Following the panel, the conversation moves from the stage to the floor — participants will join facilitated roundtable discussions focused on one key question or theme drawn from the panel dialogue.

Powered by Hellmann Worldwide Logistics

Powered by Sensitech

Falsified medicines represent a USD 30 billion annual burden on global health systems, with one in ten medicines in low- and middle-income markets now substandard or falsified. This keynote examines how anti-fragile design principles transform pharmaceutical brand protection from compliance obligation to competitive advantage. Through serialization, blockchain traceability, and cold-chain IoT monitoring, leading organizations detect counterfeits 68% faster and reduce temperature-excursion losses by 40%. Case studies from Pfizer Asia, DHL, and Singapore's HSA demonstrate measurable ROI: enhanced patient safety, faster regulatory response, and restored stakeholder confidence. Asia's harmonized serialization standards and cross-border traceability frameworks accelerate this transformation, positioning brand protection as essential infrastructure for pharmaceutical integrity.